← Leaderboards
Anna Karolina Palucka
Jackson Laboratory
$28,504,784
Attributed
$30,411,967
Total exposure
30
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$73,298,620 · 33
By mechanism
U19$46,796,941 · 17
P30$12,258,049 · 4
R01$9,284,689 · 5
U01$1,772,200 · 1
R25$1,313,384 · 1
R21$983,188 · 2
Top collaborators
- Miriam Merad5 shared
- Brent L. Berwin4 shared
- Richard A Flavell3 shared
- Adolfo Garcia-Sastre2 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Olga Anczukow-Camarda$6,475,352
- Kenneth R Johnson$13,403,402
- Gary A Churchill$29,555,134
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsCellsImmuneDendritic CellsImmune ResponseResponseResearch PersonnelT-LymphocyteImmunityImmunologySamplingIn VivoLungAntigensTissuesVirus DiseasesEnvironmentThe Jackson LaboratoryVaccinesMalignant NeoplasmsPathway InteractionsGenerationsTechnologyEpithelial Cells
Grant awards (117)
Modulation of Lung Immune Responses to Viral Infection$2,637,774
U19 · FY2025 · AI · contact PI
Cancer Center Support (CORE) Grant$2,230,200
P30 · FY2025 · CA · contact PI
Modulation of lung immunity by epithelial cells from older individuals$778,032
U19 · FY2025 · AI · contact PI
Developmental Funds$433,717
P30 · FY2025 · CA · contact PI
Sample Core$314,228
U19 · FY2025 · AI · contact PI
Short Course on Experimental Models of Human Cancer$212,259
R25 · FY2025 · CA · contact PI
Administrative Core$133,873
U19 · FY2025 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,637,774
U19 · FY2024 · AI · contact PI
Cancer Center Support (CORE) Grant$2,246,182
P30 · FY2024 · CA · contact PI
Modulation of lung immunity by epithelial cells from older individuals$729,960
U19 · FY2024 · AI · contact PI
Developmental Funds$420,630
P30 · FY2024 · CA · contact PI
Sample Core$374,154
U19 · FY2024 · AI · contact PI
Novel humanized mouse model of mucosal immunity$233,445
R21 · FY2024 · OD · contact PI
Short Course on Experimental Models of Human Cancer$213,164
R25 · FY2024 · CA · contact PI
Administrative Core$140,755
U19 · FY2024 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,200,000
U19 · FY2023 · AI · contact PI
Cancer Center Support (CORE) Grant$2,185,382
P30 · FY2023 · CA · contact PI
Modulation of Viral Antigen Presentation in the Lung$870,979
U19 · FY2023 · AI · contact PI
Automated Classification of Pediatric Soft Tissue Sarcoma from Histopathology Images$322,063
P30 · FY2023 · CA · contact PI
Novel humanized mouse model of mucosal immunity$291,555
R21 · FY2023 · OD · contact PI
Administrative Core$162,544
U19 · FY2023 · AI · contact PI
Sample Procurement and Management Core$154,236
U19 · FY2023 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,200,000
U19 · FY2022 · AI · contact PI
Cancer Center Support (CORE) Grant$2,185,382
P30 · FY2022 · CA · contact PI
Modulation of Viral Antigen Presentation in the Lung$445,279
U19 · FY2022 · AI · contact PI
Administrative Core$333,930
U19 · FY2022 · AI · contact PI
Sample Procurement and Management Core$333,930
U19 · FY2022 · AI · contact PI
Short Course on Experimental Models of Human Cancer$101,497
R25 · FY2022 · CA · contact PI
Modulation of Lung Immune Responses to Viral Infection$43,400
U19 · FY2022 · AI · contact PI
Modulation of Viral Antigen Presentation in the Lung$29,395
U19 · FY2022 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,200,000
U19 · FY2021 · AI · contact PI
Cancer Center Support (CORE) Grant$2,185,384
P30 · FY2021 · CA · contact PI
Modulation of Viral Antigen Presentation in the Lung$753,402
U19 · FY2021 · AI · contact PI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer$675,289
R01 · FY2021 · CA · contact PI
Modulation of Lung Immune Responses to Viral Infection$524,514
U19 · FY2021 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$498,316
U19 · FY2021 · AI · contact PI
Modulation of Viral Antigen Presentation in the Lung$498,316
U19 · FY2021 · AI · contact PI
Modulation of Viral Antigen Presentation in the Lung$405,600
U19 · FY2021 · AI · contact PI
Sample Procurement and Management Core$181,195
U19 · FY2021 · AI · contact PI
Short Course on Experimental Models of Human Cancer$166,769
R25 · FY2021 · CA · contact PI
Administrative Core$162,540
U19 · FY2021 · AI · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,200,000
U19 · FY2020 · AI · contact PI
Modulation of Viral Antigen Presentation in the Lung$878,401
U19 · FY2020 · AI · contact PI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer$670,182
R01 · FY2020 · CA · contact PI
Modulation of lung immunity by CoronaVirus$518,190
U19 · FY2020 · AI · contact PI
Modulation of Viral Antigen Presentation in the Lung$400,545
U19 · FY2020 · AI · contact PI
Administrative Core$235,349
U19 · FY2020 · AI · contact PI
Sample Procurement and Management Core$206,527
U19 · FY2020 · AI · contact PI
Short Course on Experimental Models of Human Cancer$160,757
R25 · FY2020 · CA · contact PI
Research Program$49,109
P30 · FY2020 · CA · contact PI
Modulation of Lung Immune Responses to Viral Infection$2,200,000
U19 · FY2019 · AI · contact PI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer$650,064
R01 · FY2019 · CA · contact PI
Modulation of Viral Antigen Presentation in the Lung$622,562
U19 · FY2019 · AI · contact PI
Short Course on Experimental Models of Human Cancer$165,149
R25 · FY2019 · CA · contact PI
Sample Procurement and Management Core$159,600
U19 · FY2019 · AI · contact PI
Administrative Core$151,045
U19 · FY2019 · AI · contact PI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer$670,182
R01 · FY2018 · CA · contact PI
Short Course on Experimental Models of Human Cancer$147,780
R25 · FY2018 · CA · contact PI
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer$697,539
R01 · FY2017 · CA · contact PI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$439,280
R01 · FY2017 · CA · contact PI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$442,010
R01 · FY2016 · CA · contact PI
Short Course on Experimental Models of Human Cancer$146,009
R25 · FY2016 · CA · contact PI
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system$467,188
R01 · FY2015 · CA · contact PI
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity$350,151
U01 · FY2015 · AI
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals$748,045
U19 · FY2014 · AI · contact PI
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity$350,152
U01 · FY2014 · AI
Administration$98,513
U19 · FY2014 · AI · contact PI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,059,835
U19 · FY2013 · AI · contact PI
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals$491,578
U19 · FY2013 · AI · contact PI
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity$350,152
U01 · FY2013 · AI
Eliciting Mucosal Immunity in Humanized Mice$315,188
U19 · FY2013 · AI · contact PI
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells$217,043
R01 · FY2013 · CA · contact PI
Cell and Tissue Procurement Core$119,003
U19 · FY2013 · AI · contact PI
Administration$76,989
U19 · FY2013 · AI · contact PI
Pilot Project$8,315
U19 · FY2013 · AI · contact PI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,034,833
U19 · FY2012 · AI · contact PI
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals$487,429
U19 · FY2012 · AI · contact PI
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells$395,213
R01 · FY2012 · CA · contact PI
Eliciting Mucosal Immunity in Humanized Mice$368,539
U19 · FY2012 · AI · contact PI
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity$350,152
U01 · FY2012 · AI
Cell and Tissue Procurement Core$162,095
U19 · FY2012 · AI · contact PI
Administration$76,337
U19 · FY2012 · AI · contact PI
Pilot Project$8,244
U19 · FY2012 · AI · contact PI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$3,077,917
U19 · FY2011 · AI · contact PI
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals$633,368
U19 · FY2011 · AI · contact PI
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs$580,820
R01 · FY2011 · CA · contact PI
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells$389,282
R01 · FY2011 · CA · contact PI
Role of Mucosal DC Subsets in the Control of Influenza A Virus Immunity$371,593
U01 · FY2011 · AI
Eliciting Mucosal Immunity in Humanized Mice$358,365
U19 · FY2011 · AI · contact PI
Cell and Tissue Procurement Core$220,629
U19 · FY2011 · AI · contact PI
Administration$115,125
U19 · FY2011 · AI · contact PI
Pilot Project$69,965
U19 · FY2011 · AI · contact PI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans$4,499,507
U19 · FY2010 · AI · contact PI
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs$578,305
R01 · FY2010 · CA · contact PI
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells$409,401
R01 · FY2010 · CA · contact PI
Eliciting Mucosal Immunity in Humanized Mice$361,985
U19 · FY2010 · AI · contact PI
Cell and Tissue Procurement Core$222,857
U19 · FY2010 · AI · contact PI
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs$546,210
R01 · FY2009 · CA · contact PI
Eliciting Mucosal Immunity in Humanized Mice$367,669
U19 · FY2009 · AI · contact PI
Cell and Tissue Procurement Core$227,134
U19 · FY2009 · AI · contact PI
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs$526,521
R01 · FY2008 · CA · contact PI
Human Vaccine Potency on Mice with a Human Immune System$271,132
U19 · FY2008 · AI · contact PI
Core--Cell$177,801
P01 · FY2008 · CA · contact PI
Increasing the Potency of Monocyte-derived DC Vaccines$148,117
P01 · FY2008 · CA · contact PI
Core--Cell$176,156
P01 · FY2007 · CA · contact PI
Increasing the Potency of Monocyte-derived DC Vaccines$146,829
P01 · FY2007 · CA · contact PI
Core--Cell$151,395
P01 · FY2006 · CA · contact PI
Increasing the Potency of Monocyte-derived DC Vaccines$89,871
P01 · FY2006 · CA · contact PI
Dendritic Cells and Breast Cancer Immunity$232,540
R01 · FY2004 · CA
Mice with Human Dendritic Cells to Test Vaccine Potency$228,750
R21 · FY2004 · AI
Dendritic Cells and Breast Cancer Immunity$232,540
R01 · FY2003 · CA
Mice with Human Dendritic Cells to Test Vaccine Potency$229,438
R21 · FY2003 · AI
Dendritic Cells and Breast Cancer Immunity$232,540
R01 · FY2002 · CA
Diversification of melanoma immunity via dendritic cells$0
P01 · FY2002 · CA
Dendritic Cells and Breast Cancer Immunity$232,540
R01 · FY2001 · CA
Diversification of melanoma immunity via dendritic cells$0
P01 · FY2001 · CA
Diversification of melanoma immunity via dendritic cells$0
P01 · FY2000 · CA